Xeris Pharmaceuticals | XERS - Loan Capital


Xeris Pharmaceuticals reported $221.22M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Celltrion KRW 412.27B 348.97B Dec/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 50M 30M Mar/2026
Eli Lilly USD 39.37B 1.5B Mar/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.62B 17.5M Mar/2026
Pharma Mar EUR 33.16M 3.52M Mar/2026
Qiagen NV USD 1.65B 15.23M Dec/2025
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026